Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Clarksterh who wrote (19692)	4/10/2006 12:08:48 AM
From: DewDiligence_on_SI	Respond to of 52153

Executive turnover is a great metric for several reasons: 1. The data are readily available from simply reading PRs and SEC filings. 2. There’s hardly any subjectivity—a given executive either left or didn’t leave. (I discount claims that someone left a company for “personal reasons” unless there is compelling evidence to back it up.) 3. Executives who leave often forfeit a sizable package of stock options; hence, leaving is tantamount to the executive’s putting a Sell rating on the stock. -- The two worst biotechs I can think of on the executive-turnover metric are DNDN and GENR. (I sold the former in 2005 and the latter in 2004.) p.s. Excellent thread.